Genentech Inc

Consistency key to port delivery system

by: lynda-charters Reviewed by Carl Regillo, MD The Port Delivery System(PDS) with ranibizumab (Lucentis, Genentech Inc.), an investigational drug delivery system designed for continuous long-term intravitreal drug delivery to treat…

Newsletter Sign-up

  • This field is for validation purposes and should be left unchanged.